Article
Response to Checkpoint Inhibitor Therapy in Advanced Classic Kaposi Sarcoma: A Case Report and Immunogenomic Study.
Journal of the National Comprehensive Cancer Network : JNCCN - 1 Jul 2018
Saller James, Walko Christine M, Millis Sherri Z, Henderson-Jackson Evita, Makanji Rikesh, Brohl Andrew S
Abstract excerpt
Kaposi sarcoma (KS) is an uncommon angioproliferative malignancy that is associated with human herpesvirus 8. Although there has been recent enthusiasm for evaluating immune checkpoint inhibition as a therapeutic option for viral-associated tumors, the clinical utility in this disease is currently unknown. We report a case of advanced classic KS refractory to multiple lines of chemotherapy that experienced a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
